TAO Synergies (TAOX) Dividends payables (2022 - 2023)
TAO Synergies' (TAOX) quarterly Dividends payables came in at $381964.0 in Q1 2023, up 229.59% quarter-over-quarter from $115890.0 in Q4 2022.
Powered by 
Analysis
TAO Synergies (TAOX) Dividends payables (2022 - 2023) Analysis & Trends
TAO Synergies (TAOX) has reported Dividends payables for 2 consecutive years, with $381964.0 the latest figure, recorded in Q1 2023.
- For the quarter ending Q1 2023, Dividends payables changed N/A year-over-year to $381964.0; the trailing twelve-month figure through Mar 2023 stood at $381964.0 (changed N/A YoY), and the FY2022 full-year result was $115890.0, changed N/A from the prior year.
- Dividends payables grew to $381964.0 in Q1 2023 per TAOX's latest filing, from $115890.0 in the prior quarter.
- Across five years, Dividends payables topped out at $381964.0 in Q1 2023 and bottomed at $115890.0 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.51 Bn | 197.52 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.48 Bn | 178.30 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.45 Bn | 124.60 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.72 Bn | 49.59 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.31 Bn | 30.31 Bn | 1.16 Mn | - |
| 10 | TAO Synergies | 30.90 Mn | 30.90 Mn | - | - |